This brief provides an overview of the Medicaid Incentives for the Prevention of Chronic Diseases (MIPCD) grants and highlights key findings from the interim evaluation of the program. The brief also places these grants in context of pre-Affordable Care Act (ACA) Medicaid beneficiary incentive programs and proposed programs of states that are incorporating healthy behavior incentives into Medicaid expansion waivers.
- state & global data
- view as grid
- view as list
The Affordable Care Act (ACA) requires most private health insurance plans to provide coverage for a broad range of preventive services including FDA approved prescription contraceptives and services for women. Legal challenges and recently issued rules have affected contraceptive coverage for many women.
This short fact sheet answers questions about how where a woman works may affect the contraceptive coverage she may receive.
This November 16, 2010, webcast features an expert panel exploring the future of U.S. multilateral engagement on global health. It is part of the Foundation’s U.S. Global Health Policy: In Focus series.
As one of the cornerstones of global health, widespread immunization through vaccines is critical to reducing child mortality and eradicating polio, two goals endorsed by the international community and particularly emphasized by the U.S. government. This live, interactive webcast explores the importance of vaccines in global child survival efforts, including the role of the U.S. government, the GAVI Alliance, and NGOs. Panelists discuss the current state of childhood immunization, global investments in vaccines, and the opportunities and challenges faced by key stakeholders. This webcast is part of “U.S. Global Health Policy: In Focus”, a Kaiser Family Foundation studio webcast series devoted to discussing current and critical issues facing the U.S.
Insurance Coverage and Access to HIV Testing and Treatment: Considerations for Individuals at Risk for Infection and for Those with Undiagnosed Infection
Of the estimated 1.2 million people living with HIV/AIDS in the United States, approximately 500,000 are not receiving care for their disease. This includes an estimated 250,000 people who do not know they are HIV positive. This article reviews data on insurance coverage and access to HIV testing and treatment,…
The Patient Protection and Affordable Care Act (ACA) requires most private plans to provide coverage for women’s preventive health care, including all prescribed FDA-approved contraceptive services, without cost sharing. To better understand how this provision is being implemented by health plans, Kaiser Family Foundation (KFF) staff, with the Lewin Group, reviewed the insurance plan coverage policies for 12 prescribed contraceptive methods (excluding oral contraceptives). This report presents information from 20 different insurance carriers in five states (California, Georgia, Michigan, New Jersey, and Texas) about how they are applying reasonable medical management (RMM) techniques in their coverage of women’s contraceptive services. The different forms of female birth control reviewed in this report include the contraceptive ring, the patch, injections, implants, intrauterine devices (IUDs), and sterilization.
Intrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews the various IUDs approved by the FDA; awareness, use, and availability of IUDs; and key issues in insurance coverage and financing of IUDs in the United States.
This fact sheet reviews how coverage of contraceptives varies between private insurance under the Affordable Care Act (ACA) and publicly-funded programs, including Medicaid, Medicare, TRICARE, the Indian Health Service, and Title X funded clinics.